Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
8.13
-0.15 (-1.81%)
Feb 23, 2026, 12:34 PM EST - Market open
Personalis Market Cap
Personalis has a market cap or net worth of $721.98 million as of February 23, 2026. Its market cap has increased by 90.73% in one year.
Market Cap
721.98M
Enterprise Value
618.67M
1-Year Change
90.73%
Ranking
Category
Stock Price
$8.13
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $721.98M, a decrease of -14.82%. That is a compound annual growth rate of -2.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 735.30M | 4.02% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neogen | 2.46B |
| GeneDx Holdings | 2.37B |
| GRAIL | 2.03B |
| NeoGenomics | 1.28B |
| CareDx | 966.93M |
| OPKO Health | 921.24M |
| Castle Biosciences | 852.60M |
| Fulgent Genetics | 716.55M |